Consensus ChampionX Corporation

Equities

CHX

US15872M1045

Oil Related Services and Equipment

Real-time Estimate Cboe BZX Other stock markets 17:29:13 23/06/2025 BST			5-day change	1st Jan Change
25.72 ^USD	-2.22%		-2.44%	-5.28%

06-20	UK Watchdog Seeks Feedback on Proposed Undertakings in Schlumberger-ChampionX Merger	MT
06-20	U.K. Regulator Opens Consultation into SLB, ChampionX's Undertakings Ahead of Final Decision	DJ

Evolution of the Average Target: ChampionX Corporation

Evolution of the Target Price: ChampionX Corporation

Changes in Analyst Recommendations: ChampionX Corporation

aec730837feb52687fbb73438fb9917.PghJ-yx5gOeOK2b43N5MSPZjraQXvcBPBVytE3Evk44.UmMzsWVAsY_FbwitpoR7Ls8wztRHybkdSBfBKhpDwfhySRCWZA3ioPQaXg~295511963f8684e04bf7a43bcb65a479

Analysts' recommendations: ChampionX Corporation

Piper Sandler Cuts ChampionX Price Target to $33 From $40, Maintains Neutral Rating	15/07/24	MT
Piper Sandler Raises ChampionX's Price Target to $40 From $32, Maintains Neutral Rating	08/04/24	MT
Barclays Raises Price Target on ChampionX to $51 From $39, Maintains Overweight Rating	04/04/24	MT
RBC Raises Price Target on Schlumberger to $69 From $66 Amid ChampionX Deal, Keeps Outperform Rating	03/04/24	MT
Piper Sandler Downgrades ChampionX to Neutral From Overweight, Adjusts Price Target to $32 From $38	08/01/24	MT
Goldman Sachs Cuts Price Target on ChampionX to $32 From $37, Maintains Neutral Rating	14/11/23	MT
Piper Sandler Adjusts Price Target on ChampionX to $38 From $42, Maintains Overweight Rating	27/10/23	MT
Barclays Upgrades ChampionX to Overweight Equal-Weight, Raises Price Target to $44 From $33	17/10/23	MT
Capital One Initiates ChampionX With Overweight Rating, $40 Price Target	14/07/23	MT
Citigroup Trims Price Target on ChampionX to $40 From $41, Maintains Buy Rating	05/04/23	MT
Goldman Sachs Adjusts ChampionX's Price Target to $32 From $21, Keeps Neutral Rating	02/11/22	MT
Citigroup Adjusts ChampionX Price Target to $34 From $30, Maintains Buy Rating	01/11/22	MT
Barclays Downgrades ChampionX to Equalweight From Overweight, Reduces Price Target to $28 From $38	06/10/22	MT
Analyst recommendations: Nvidia, Thermo Fisher Scientific, Danaher, Agilent Technologies, GDS Holdings...	25/08/22
Benchmark Starts ChampionX at Buy With $32 Price Target	25/08/22	MT
BofA Securities Upgrades ChampionX to Buy From Neutral; Price Target is $22	15/07/22	MT
Goldman Sachs Lowers Price Target for ChampionX to $21 From $26, Maintains Neutral Rating	12/07/22	MT
Barclays Adjusts ChampionX's Price Target to $38 from $33, Keeps Overweight Rating	02/05/22	MT
Piper Sandler Lifts ChampionX to Overweight From Neutral, Price Target to $30 From $28	11/04/22	MT
BofA Securities Downgrades ChampionX to Neutral from Buy	11/03/22	MT
Goldman Sachs Upgrades ChampionX to Neutral From Sell; Price Target is $24	22/02/22	MT
Barclays Adjusts Price Target on ChampionX to $35 From $29, Reiterates Overweight Rating	01/11/21	MT
CHAMPIONX : Goldman Sachs Starts ChampionX at Sell With $22 Price Target	17/09/21	MT
Analyst recommendations: Anthem, GlaxoSmithKline, Flutter, IMI, Workspace...	05/07/21
CHAMPIONX : Stifel Adjusts Price Target on ChampionX to $30 From $26, Maintains Buy Rating	02/07/21	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus (Composite)	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Ecart obj. / dr
	CHAMPIONX CORPORATION					+55.07%
	SCHLUMBERGER LIMITED					+31.95%
	BAKER HUGHES COMPANY					+19.08%
	HALLIBURTON COMPANY					+29.85%
	TECHNIPFMC PLC					+0.07%
	CNOOC ENERGY TECHNOLOGY & SERVICES LIMITED					+9.81%
	SAIPEM S.P.A.					+28.08%
	NOV INC.					+21.03%
	SBM OFFSHORE N.V					+13.28%
	ARCHROCK, INC.					+23.8%
	Average					+23.20%
	Weighted average by Cap.					+23.91%